Fennec Pharmaceuticals (FENC) Net Cash Flow Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.65% |
| Sep 30, 2025 | 20.90% |
| Jun 30, 2025 | -16.41% |
| Mar 31, 2025 | -1.10% |
| Dec 31, 2024 | -53.81% |
| Sep 30, 2024 | -4.11% |
| Jun 30, 2024 | -24.15% |
| Mar 31, 2024 | 75.96% |
| Dec 31, 2023 | 20.10% |
| Sep 30, 2023 | -18.05% |
| Jun 30, 2023 | -26.04% |
| Mar 31, 2023 | -28.43% |
| Dec 31, 2022 | -18.35% |
| Sep 30, 2022 | 96.47% |
| Jun 30, 2022 | -19.91% |
| Mar 31, 2022 | -33.30% |
| Dec 31, 2021 | -39.56% |
| Sep 30, 2021 | -40.31% |
| Jun 30, 2021 | -24.37% |
| Mar 31, 2021 | -55.36% |
| Dec 31, 2020 | -46.10% |
| Sep 30, 2020 | -62.70% |
| Jun 30, 2020 | 241.87% |
| Mar 31, 2020 | -57.16% |
| Dec 31, 2019 | -23.97% |
| Sep 30, 2019 | -39.57% |
| Jun 30, 2019 | -53.54% |
| Mar 31, 2019 | -50.98% |
| Dec 31, 2018 | -28.83% |
| Sep 30, 2018 | -18.93% |
| Jun 30, 2018 | -3.95% |
| Mar 31, 2018 | -30.51% |
| Dec 31, 2017 | 104.01% |
| Sep 30, 2017 | 5.61% |
| Jun 30, 2017 | 52.18% |
| Mar 31, 2017 | -3.15% |
| Dec 31, 2016 | 4.45% |
| Sep 30, 2016 | 3.08% |
| Jun 30, 2016 | 20.68% |
| Mar 31, 2016 | 17.65% |
| Dec 31, 2015 | 8.33% |
| Sep 30, 2015 | 2.36% |
| Jun 30, 2015 | -14.97% |